Tag: Seaport Therapeutics
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
Forecasting the future: GridBeyond’s new tool supports smarter energy planning
As Australia’s energy landscape grows more dynamic, businesses operating in the National Electricity Market (NEM) face increasing challenges – from rising costs and evolving regulations to the growing presence of decentralised and renewable energy sources.
